3D-Printed Microneedles with Controlled Structures for Drug Delivery Study in an Ex Vivo Model

Wei Dong, Wei Yang, Xiang Song, Fu LiuMicromachines 2025 · DOI

TL;DR

This paper introduces a novel approach to fabricating microneedle arrays (MNAs) for transdermal drug delivery using stereolithography (SLA) 3D printing. By leveraging SLA, the researchers demonstrate the ability to create MNAs with precisely controlled complex structures, leading to improved drug loading capacity and reduced insertion force compared to traditional conical designs.

What Problem Does This Paper Address?

Transdermal drug delivery using microneedles offers a less painful and more compliant alternative to traditional injections. However, traditional methods for fabricating microneedles are often complex, time-consuming, and limit design flexibility, hindering the development of advanced microneedle structures that could optimize drug delivery. Specifically, achieving precise control over microneedle geometry, such as channel structures, to enhance drug loading and reduce insertion force has been a significant challenge. This paper aims to overcome these limitations by utilizing 3D printing to create customized microneedle designs with controlled structures for improved transdermal drug delivery.

Methods

The core of this research lies in the application of Stereolithography (SLA) 3D printing for microneedle fabrication. This technique uses UV light to selectively cure liquid resin layer by layer, allowing for high precision and the creation of complex geometries.

Key methodological aspects include:

  • CAD Design and Slicing: Microneedle designs, including conical, grooved (spiral and cambered), and hollow structures, were created using CAD software (Inventor 2015) and then sliced into thin layers (25 µm) using preprocessing software (PreForm).
  • SLA Printing: A Form2 SLA printer was used with a 405 nm laser and 250 mW power, featuring a 140 µm laser spot size and a layer thickness of 25 µm. The printing process involved bottom-up irradiation for layer-by-layer curing.
  • Post-processing: Printed microneedles were washed in isopropyl alcohol to remove excess resin and then UV-cured for 20 minutes to enhance mechanical properties.
  • Mechanical Testing: An MTS tester was used to perform ex vivo penetration assays on porcine skin. Force-displacement data were recorded to measure insertion force and evaluate the effect of microneedle geometry on penetration.
  • Drug Loading and Release Study: Methylene blue was used as a surrogate drug. Microneedles were coated using a dip-coating method. Drug loading capacity was quantified, and ex vivo release studies were conducted on porcine skin, with diffusion observed using optical microscopy and ImageJ for analysis.

Datasets

Not discussed in the paper. The study utilizes ex vivo porcine skin as a model for evaluating microneedle performance.

Key Insights and Ideas

  • SLA as a Game-Changer for Microneedle Design: The study highlights SLA's capability to move beyond simple conical designs and create intricate, controlled structures like grooves and channels in a single, efficient step. This opens doors for highly customized microneedle arrays.
  • Grooved Structures Enhance Drug Loading: The introduction of spiral and cambered grooves significantly increases the surface area available for drug coating, leading to a substantial improvement in drug loading capacity compared to solid conical microneedles.
  • Channel Structures Reduce Insertion Force: The presence of channel structures on the microneedle bodies appears to reduce the contact area with the skin during insertion, leading to a lower required insertion force. This suggests a potential for reduced pain and improved patient comfort.
  • Tunable Release Profiles: The controlled geometry of the microneedles, particularly the grooved designs, influences drug release kinetics, demonstrating the potential for tailoring release profiles for different therapeutic needs.
  • Efficiency of 3D Printing: The paper emphasizes the speed and cost-effectiveness of SLA printing for microneedle fabrication, producing an 8x8 array in just 55 minutes, a significant improvement over traditional methods.

Key Results

  • Reduced Insertion Force: The grooved microneedle design required a minimal force of approximately 2.2 N for full insertion at a tip angle of 18.92°. This is notably lower than forces reported for metallic microneedles.
  • Enhanced Drug Loading Capacity: Grooved microneedles demonstrated an improved drug loading capacity of 4.8 µg released over 2 hours, which is nearly double that of conical microneedles (2.3 µg).
  • Efficient Penetration: All fabricated microneedle types successfully pierced the porcine skin without structural fracture.
  • Rapid Drug Release: Approximately 35% of the loaded pigment was released within the first 30 minutes, with the majority released within 2 hours, indicating effective delivery into the skin.
  • Fabrication Speed: An 8x8 microneedle array was fabricated in just 55 minutes, showcasing the efficiency of the SLA printing process.

Limitations and Future Work

  • Ex Vivo Model: The study was conducted using an ex vivo porcine skin model. While a good surrogate, further in vivo studies are needed to fully validate the performance and safety in living subjects.
  • Biocompatibility and Stability: The authors acknowledge that the biocompatibility of the microneedle device and the stability of the printing material require further investigation for clinical translation.
  • Reaction Completion and Residual Polymer: Ensuring complete reaction completion during photopolymerization and thorough removal of residual polymer are critical for future device development.
  • Cargo Loading Methods: While dip coating was used, further exploration of various cargo loading and encapsulation methods is warranted.
  • In-depth Structural Parameter Analysis: The study lacked an in-depth analysis of how specific structural parameters precisely affect drug delivery performance. Future work will focus on defining these relationships.
  • Qualitative Biocompatibility Evaluation: The authors suggest that a qualitative biocompatibility evaluation would be beneficial.

Summary updated

Abstract

MN arrays are highly beneficial for transdermal drug delivery, primarily due to reduced pain and improved compliance. However, complex processing and restricted design freedom limit traditional fabrication. We utilized stereolithography (SLA) 3D printing as a breakthrough method to achieve the one-step production of MN arrays with customized geometries (structure, size, tip angle), enabling tunable release profiles and eliminating cumbersome manufacturing steps. After fabricating conical and grooved MN arrays and validating them in an ex vivo porcine skin model, we confirmed their functionality. Notably, the grooved design provided excellent penetration, requiring only 2.2 N of force for full insertion (at 18.92° tip angle), and demonstrated an enhanced drug loading capacity of 4.8 μg released over 2 h. These results underscore the significant potential of 3D-printed, channel-structured MN arrays as a new generation of high-performance transdermal delivery devices.
BibTeX
@inproceedings{dong2025d,
  author = {Wei Dong and Wei Yang and Xiang Song and Fu Liu},
  title = {{3D-Printed Microneedles with Controlled Structures for Drug Delivery Study in an Ex Vivo Model}},
  booktitle = {Micromachines},
  year = {2025},
  doi = {10.3390/mi16111249},
}
Figure